Page results
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
UCLH vision, values and strategy
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This page explains what an intra-oral scanner is and what it is used for.
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
File results
-
FOI/2024/0578 - Public identity insurance policies held by Fertility Clinic that cover data breaches
-
FOI/2024/0580 - Newborns taken into care from the maternity wards 2019-2023
-
FOI/2024/0581 - Weight management services/ bariatric surgery/ access to Wegovy
-
FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2024/0583 - National inpatient survey improvements/ night-time noise levels/ ward lighting/ mealtime support
-
FOI/2024/0589 - SACT Cancer report/ Drug Patient Level Contract Monitoring (DrPLCM) report
-
FOI/2024/0595 - Capital estate activity for 2020-2024
-
FOI/2024/0594 - Implementation of Federated Data Platform (FDP) and procurement of data platforms
-
FOI/2024/0439 - Digital dictation provider
-
FOI/2024/0587 - Colorectal cancer treatments